Global manufacturer of cardiovascular medical devices BIOTRONIK announced the release of its Renamic product for the Japanese market. The announcement is in response to the dramatic growth of cardiac ...
BERLIN--(BUSINESS WIRE)--BIOTRONIK SE & Co. KG announced today the European market launch of their new Renamic implantable cardiac device programmer. Renamic is the latest addition to BIOTRONIK’s new ...
LAKE OSWEGO, Ore., Aug. 31, 2022 /PRNewswire/ -- BIOTRONIK's LiveSupport feature has been successfully used to remotely support Cardiac Rhythm Management (CRM) clinics. This new technology enables ...
LAKE OSWEGO, Ore., Aug. 29, 2023 /PRNewswire/ -- BIOTRONIK, a leader in implantable medical device technology, today announced its first US implantation of the new Amvia Edge pacemaker. The procedure ...
LAKE OSWEGO, Ore.-- (BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has granted approval for its ...
December 8, 2011 (Rennes, France) — Remote monitoring of patients with dual-chamber pacemakers "was a safe substitute for conventional follow-ups, decreased the number of [clinic] visits, and enabled ...
Biotronik is looking to get the FDA's approval for a line of MRI-safe pacemakers--courtesy of Biotronik The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate ...
First US Patients Implanted with Itrevia HF-T QP, Incorporating Latest Defibrillator Technology, Closed Loop Stimulation and Compatibility with a Quadripolar Lead, to Help Patients with Heart Failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results